<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Gas Res</journal-id><journal-id journal-id-type="publisher-id">MGR</journal-id><journal-id journal-id-type="publisher-id">Med Gas Res</journal-id><journal-title-group><journal-title>Medical Gas Research</journal-title></journal-title-group><issn pub-type="epub">2045-9912</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC466979</article-id><article-id pub-id-type="publisher-id">MGR-14-145</article-id><article-id pub-id-type="doi">10.4103/2045-9912.385945</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Neuroprotective effects of hydrogen sulfide in Parkinson&#x02019;s disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Yang</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jinhui</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Shen</surname><given-names>Haitao</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9296-3725</contrib-id><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yu</surname><given-names>Zhengquan</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Gang</given-names></name><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Department of Neurosurgery &#x00026; Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China</aff><author-notes><corresp id="cor1"><label>*</label><italic toggle="yes"><bold>Correspondence to:</bold> Haitao Shen, <email xlink:href="shenhaitao1990@suda.edu.cn">shenhaitao1990@suda.edu.cn</email>; Zhengquan Yu, <email xlink:href="zhengquan_yu@126.com">zhengquan_yu@126.com</email></italic>.</corresp><fn id="fn1"><label>#</label><p><italic toggle="yes">Both authors have contributed equally to this work</italic>.</p></fn></author-notes><pub-date pub-type="collection"><season>Jul-Sep</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2023</year></pub-date><volume>14</volume><issue>3</issue><fpage>145</fpage><lpage>148</lpage><history><date date-type="received"><day>25</day><month>5</month><year>2022</year></date><date date-type="rev-recd"><day>01</day><month>8</month><year>2022</year></date><date date-type="accepted"><day>14</day><month>6</month><year>2023</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Medical Gas Research</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Hydrogen sulfide (H<sub>2</sub>S) has been considered to be a toxic gas with a rotten egg smell for decades. However, over the past two decades, many studies have shown that H<sub>2</sub>S has many pathological and physiological effects on mammalian body systems as a third endogenous gaseous mediator along with carbon monoxide and nitric oxide.<xref rid="R1" ref-type="bibr">1</xref> H<sub>2</sub>S is a sulfur analog of water molecules in structure and can be oxidized to the elements sulfur, thiosulfate, sulfate, and sulfur dioxide.<xref rid="R2" ref-type="bibr">2</xref></p><p>Low dose and controlled release of hydrogen sulfide can improve the function of a variety of immune cells and protect them from dysfunction caused by various harmful stimuli, such as reactive oxygen species (ROS) or oxidized low-density lipoprotein. These effects of H<sub>2</sub>S help maintain immune function, stimulate antibacterial defense and play an anti-inflammatory role in various diseases.<xref rid="R3" ref-type="bibr">3</xref> Studies show neuroprotective function of H<sub>2</sub>S in several central nervous system diseases including Parkinson&#x02019;s disease (PD), ischemic stroke, traumatic brain injury and Alzheimer&#x02019;s disease.<xref rid="R4" ref-type="bibr">4</xref><xref rid="R5" ref-type="bibr">5</xref> Both <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro,</italic> H<sub>2</sub>S has been demonstrated to exert antioxidant, anti-inflammatory and anti-apoptotic effects under pathological conditions.<xref rid="R6" ref-type="bibr">6</xref> H<sub>2</sub>S promotes the induction of long-term enhancement in the hippocampus by enhancing the activity of N-methyl-D-aspartate receptor, and then forms a synaptic model of memory. H<sub>2</sub>S can also increase the concentration of Ca<sup>2+</sup> in glial cells, induce Ca<sup>2+</sup> waves and mediate the transmission of glial signals.<xref rid="R7" ref-type="bibr">7</xref> H<sub>2</sub>S significantly reduced the severity of neuroinflammation in the rat model of traumatic brain injury and restored the neurotrophic factors that characterize the secondary events of traumatic brain injury.<xref rid="R8" ref-type="bibr">8</xref> Endogenous H<sub>2</sub>S synthesis decreases after intracerebral hemorrhage, and H<sub>2</sub>S can reduce secondary brain injury caused by neuroinflammatory response by inhibiting P2X7 receptor.<xref rid="R9" ref-type="bibr">9</xref> After intracerebral hemorrhage, sodium hydrogen sulfide (NaHS) supplementation can increase the production of endogenous H<sub>2</sub>S. In the Morris water maze test, H<sub>2</sub>S reduces brain edema, lesion volume and neurological deficit after intracerebral hemorrhage.<xref rid="R10" ref-type="bibr">10</xref></p><p>PD is the second most common neurodegenerative disease after Alzheimer&#x02019;s disease. According to statistics, approximately 2% of the global population over the age of 65 years is affected by PD.<xref rid="R11" ref-type="bibr">11</xref> The number of patients is expected to increase from 8.7 million to 9.3 million by 2030.<xref rid="R12" ref-type="bibr">12</xref> High-risk factors for PD include consumption of dairy products, exposure to pesticides, history of melanoma, and traumatic brain injury, while caffeine, smoking, physical activity, higher serum urate concentrations, and use of ibuprofen and other common medications can reduce the incidence of the disease.<xref rid="R13" ref-type="bibr">13</xref> Typical symptoms of PD include bradykinesia, rigidity, postural instability and resting tremor. The main pathological mechanism of these symptoms is the massive loss of dopaminergic neurons in the substantia nigra pars compacta.<xref rid="R14" ref-type="bibr">14</xref> The typical pathological features of PD are the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of misfolded &#x003b1;-synuclein, which is present in intracytoplasmic inclusions called Lewy bodies.<xref rid="R15" ref-type="bibr">15</xref> In general, the first-class drug for PD is levodopa, but it only improves the symptoms, not the loss of dopaminergic neurons. One possible mechanism is oxidative stress-induced neuronal loss, including oxidation of levodopa, and the other is neurotoxins produced by activated microglia and astrocytes.<xref rid="R16" ref-type="bibr">16</xref> Treatment for PD is symptomatic, with an emphasis on improving nonmotor (e.g., cognition, mood, sleep, constipation) and motor (e.g., rigidity, tremor, bradykinesia) signs and symptoms.<xref rid="R17" ref-type="bibr">17</xref> There is no drug treatment that improves the disease. Therefore, it is important to develop effective therapeutic drugs or strategies that can reverse disease progression.<xref rid="R18" ref-type="bibr">18</xref> Various <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> PD models have demonstrated that supplementation of H<sub>2</sub>S reverses the loss of dopaminergic neurons and attenuates dyskinesia in PD patients.<xref rid="R5" ref-type="bibr">5</xref></p><p><bold>The production and physiological role of endogenous H<sub>2</sub>S:</bold> The expression of H<sub>2</sub>S-catalyzed enzymes in the cardiovascular system, neuronal system, immune system, renal system, respiratory system, gastrointestinal system, reproductive system, liver system and endocrine system varies widely.<xref rid="R19" ref-type="bibr">19</xref> The synthesis of endogenous H<sub>2</sub>S in mammals mainly depends on three enzymes including cystathionine &#x003b2; synthase (CBS), cystathionine &#x003b3;-lyase (CSE) and 3-mercaptopyruvate sulfur transferase, which convert cysteine or cysteine derivatives into H<sub>2</sub>S in different tissues and organs.<xref rid="R20" ref-type="bibr">20</xref> CSE and CBS are key enzymes in the reverse transsulfuration pathway, which results in sulfur transfer from homocysteine to cysteine. CSE and CBS generate H<sub>2</sub>S through several different reactions.<xref rid="R21" ref-type="bibr">21</xref> CSE can use homocysteine or cysteine to produce H<sub>2</sub>S with the help of 5-neneneba pyridoxal phosphate. CBS produces H<sub>2</sub>S not only through cysteine, but also through the combination of cysteine and homocysteine. CBS can also produce H<sub>2</sub>S from homocysteine alone, but the enzyme activity of CBS is inhibited when homocysteine levels are high. 3-Mercaptopyruvate sulfur transferase works with cysteine aminotransferase to produce H<sub>2</sub>S.<xref rid="R22" ref-type="bibr">22</xref> CBS is found primarily in cerebellar Bergmann glia and astrocytes in the brain. Transforming growth factor-&#x003b1;, epidermal growth factor, cyclic adenosine phosphate and dexamethasone promote CBS expression in astrocytes. In addition, S-adenosyl methionine as a CBS activator can also promote the enzymatic production of H<sub>2</sub>S.<xref rid="R23" ref-type="bibr">23</xref> One study showed that in the central nervous system, CBS was highly expressed only in astrocytes compared to microglia and neurons. <italic toggle="yes">In vitro,</italic> astrocytes synthesize H<sub>2</sub>S 7.57 times faster than microglia.<xref rid="R24" ref-type="bibr">24</xref> A study by Li et al.<xref rid="R25" ref-type="bibr">25</xref> found that H<sub>2</sub>S improves silent information regulator 1 activity by accelerating SIRT sulfation, thereby increasing autophagic flux and attenuating 1-methyl-4-phenylpyridinium-induced damage in SH-SY5Y cells. H<sub>2</sub>S acts as a neuromodulator and alters hippocampal long-term potentiation by selectively enhancing N-methyl-D-aspartate receptor-mediated currents in a memory synapse model.<xref rid="R26" ref-type="bibr">26</xref> Physiological concentrations of H<sub>2</sub>S increase cyclic adenosine phosphate production with downstream effects on camp stimulated intracellular pathways in brain cells, neurons and glial cell lines.<xref rid="R27" ref-type="bibr">27</xref> H<sub>2</sub>S induces calcium waves/elevation in both astrocytes and microglia.<xref rid="R28" ref-type="bibr">28</xref></p><p>
<bold>Mechanisms of H<sub>2</sub>S in preventing the progression of PD:</bold>
</p><p><bold><italic toggle="yes">Anti-oxidative stress:</italic></bold> Oxidative stress is the result of ROS-mediated damage to biological macromolecules and is a major factor in inflammation, cardiovascular diseases, neurodegenerative diseases, diabetes, atherosclerosis, aging, etc.<xref rid="R29" ref-type="bibr">29</xref> Oxidative phosphorylation is a major energy source for many cells, and endogenous ROS are by-products of oxidative phosphorylation. ROS are generated when oxidative phosphorylation is inefficient, resulting in oxidative stress that affects mitochondrial metabolism. In the central nervous system, oxidative stress leads to protein oxidation, lipid peroxidation, and mitochondrial DNA mutations that lead to neuronal cell death.<xref rid="R30" ref-type="bibr">30</xref> Glutathione is a major intracellular antioxidant, and oxidative stress reduces its concentration. H<sub>2</sub>S supplements glutathione levels, especially reduced glutathione, by increasing the activity of cystine/glutamate antiporters and cysteine transporters, thereby increasing the intracellular concentration of cysteine, which is the substrate for the production of glutathione.<xref rid="R31" ref-type="bibr">31</xref> H<sub>2</sub>S produced in mitochondria can directly inhibit oxidative stress.<xref rid="R32" ref-type="bibr">32</xref> In a study by Tang et al.,<xref rid="R33" ref-type="bibr">33</xref> 1-methy-4-phenylpyridinium ion (MPP+) promoted the production of ROS, particularly superoxide anion, and H<sub>2</sub>S attenuated MPP+-induced ROS accumulation. Inhibition of CBS activity and H<sub>2</sub>S production promotes ROS accumulation. Nicotinamide adenine dinucleotide phosphate oxidase produces neurotoxic oxidative stress, which is commonly thought to be involved in neurodegenerative diseases. A study by Hu et al.<xref rid="R34" ref-type="bibr">34</xref> in 2010 found that H<sub>2</sub>S can reduce 6-hydroxydopamine (6-OHDA)-induced ROS production through inhibiting nicotinamide adenine dinucleotide phosphate oxidase, thereby protecting neurons from 6-OHDA-induced damage. MPP+ induced SH-SY5Y cells to produce a large number of oxidative stress related factors such as malondialdehyde and ROS, while NaHS pretreatment could antagonize the increase in ROS and malondialdehyde levels. The levels of reduced glutathione and superoxide dismutase decreased after MPP+ induction. NaHS pretreatment could significantly reduce the consumption of glutathione induced by MPP<sup>+</sup>.<xref rid="R11" ref-type="bibr">11</xref></p><p><bold><italic toggle="yes">Anti-apoptosis:</italic></bold> A study by Jiao et al.<xref rid="R35" ref-type="bibr">35</xref> in 2019 found that H<sub>2</sub>S significantly reduced the expression of Caspase 3 and Caspase 9 by inhibiting the activation of the nuclear factor kappa-B signaling pathway and the release of cytokines in PD rats, thereby reducing cell apoptosis. Lu et al.<xref rid="R18" ref-type="bibr">18</xref> found that H<sub>2</sub>S reversed the up-regulated protein expression of glucose-regulated protein 78, C/EBP homologous protein, and Caspase 12 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. However, these apoptosis-related proteins were still up-regulated when uncoupling protein 2 was knocked out.<xref rid="R18" ref-type="bibr">18</xref> Caspase 3 and Bcl-2/Bax ratio are both important biomarkers for evaluating MPP<sup>+</sup> mediated apoptosis. Activated Caspase 3 is a key molecule in apoptosis and is involved in growth stimulation.<xref rid="R36" ref-type="bibr">36</xref> After treatment with MPP+, the activity of Caspase 3 was up-regulated and the Bcl-2/Bax ratio was decreased. Pretreatment with 200 &#x003bc;M NaHS significantly reduced MPP<sup>+</sup>-induced Caspase 3 activity and prevented the reduction of Bcl-2/Bax ratio.<xref rid="R11" ref-type="bibr">11</xref> Hu et al.<xref rid="R28" ref-type="bibr">28</xref> found that H<sub>2</sub>S can inhibit apoptosis by regulating K-ATP channel/p38- and c-Jun N-terminal kinase/ mitogen-activated protein kinase pathways in rotenone-induced PD model <italic toggle="yes">in vitro</italic>.</p><p><bold><italic toggle="yes">Anti-inflammatory:</italic></bold> Neuroscientists found a link between brain degeneration and persistent inflammation after collecting data from studies in the general field of neurodegenerative diseases.<xref rid="R37" ref-type="bibr">37</xref> Classical activation of microglia (resident mononuclear phagocytes of the central nervous system) has been observed in the brains of patients with PD and can be experimentally triggered by alpha-synuclein. Although activation of microglia is required to maintain the integrity of the central nervous system, unregulated inflammatory responses and the release of pro-inflammatory cytokines and ROS can also lead to neurotoxicity, such as reduced neurogenesis, resulting in neuronal loss and altered neuronal patterns of synaptic plasticity.<xref rid="R38" ref-type="bibr">38</xref> NaSH (H<sub>2</sub>S donor) not only inhibited the up-regulated expression of microglial activation marker ED-1 in PD rats, but also reduced the accumulation of rotenone-induced inflammatory factors including NO<sub>x</sub> (NO<sub>3</sub><sup>&#x02212;</sup> and NO<sub>2</sub><sup>&#x02212;</sup>) and tumor necrosis factor-&#x003b1; in rat striatum. Therefore, NaHS may inhibit the progression of PD by reducing microglia activation.<xref rid="R34" ref-type="bibr">34</xref> 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine increased the number of activated microglias and astrocytes in the substantia nigra and, in the striatum, the number of activated microglias. Inhalation of H<sub>2</sub>S prevented 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced activation of microglia and astrocytes.<xref rid="R16" ref-type="bibr">16</xref><xref rid="R39" ref-type="bibr">39</xref><xref rid="R40" ref-type="bibr">40</xref> H<sub>2</sub>S reduces the activation of microglia, astrocytes and inflammatory factors released by THP-1 and U373 cell lines, including tumor necrosis factor-&#x003b1;, interleukin-6 and nitric oxide. H<sub>2</sub>S released from L-dopa hybrid molecule also inhibits monoamine oxidase B activity. Therefore, the anti-inflammatory and antioxidant effects of H<sub>2</sub>S may have a therapeutic effect on PD.<xref rid="R16" ref-type="bibr">16</xref></p><p><bold><italic toggle="yes">Other possible mechanisms:</italic></bold> Xie et al.<xref rid="R41" ref-type="bibr">41</xref> found that H<sub>2</sub>S significantly reduced 6-OHDA-induced endoplasmic reticulum stress responses, including upregulation of eukaryotic initiation factor-2a phosphorylation levels, glucose-regulated protein 78 and C/EBP homologous protein expression. H<sub>2</sub>S inhibits endoplasmic reticulum stress primarily by blocking Akt activity with Akt inhibitors or by inhibiting heat shock protein 90 with geldanamycin. The decrease in Akt activity also reduced the protein abundance of heat shock protein 90 in SH-SY5Y cells. Therefore, H<sub>2</sub>S may reduce the damage caused by 6-OHDA-induced endoplasmic reticulum stress through the Akt-heat shock protein 90 pathway.<xref rid="R41" ref-type="bibr">41</xref> Glucose-regulated protein 78 and C/EBP homologous protein are endoplasmic reticulum stress-related proteins. Minaei et al.<xref rid="R14" ref-type="bibr">14</xref> confirmed by immunohistochemistry and western blot that 6-OHDA causes high expression of these two cells in rat striatum, and NaHS treatment can reduce the overexpression of these proteins by more than 60% (<bold><xref rid="F1" ref-type="fig">Figure 1</xref></bold>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>H<sub>2</sub>S protects dopaminergic neurons in animal models through anti-inflammation, anti-apoptosis, anti-oxidative stress and anti-ER stress.</p><p>Note: Created by Figdraw. AKT: Protein kinase B; CHOP: C/EBP homologous protein; ER: endoplasmic reticulum; GRP78: glucose-regulated protein 78; H<sub>2</sub>S: hydrogen sulfide; Hsp90: heat shock protein 90; MDA: malondialdehyde; NAPDH: nicotinamide adenine dinucleotide phosphate; NF-&#x003ba;B: nuclear factor kappa-B; ROS: reactive oxygen species; UCP2: uncoupling protein 2.</p></caption><graphic xlink:href="MGR-14-145-g001" position="float"/></fig><p><bold>Current limitations:</bold> Although H<sub>2</sub>S has neuroprotective effects and is a promising treatment for central neurodegenerative diseases, there are still many difficulties before it can be put into clinical use. Many studies have shown that H<sub>2</sub>S has beneficial effects at physiological concentrations, but harmful effects at higher concentrations.<xref rid="R11" ref-type="bibr">11</xref><xref rid="R42" ref-type="bibr">42</xref> Therefore, the treatment window of H<sub>2</sub>S is narrow, and it is difficult to maintain a relatively stable concentration of H<sub>2</sub>S in the brain. Several inhibitors of H<sub>2</sub>S synthesis in common use today, such as AOAA and hydroxylamine, are not specific to H<sub>2</sub>S biosynthesis and may be involved in other physiological functions. Although H<sub>2</sub>S has been shown to be beneficial in PD rat models, specific concentrations of H<sub>2</sub>S in the rat substantia nigra and striatum are currently difficult to detect.<xref rid="R4" ref-type="bibr">4</xref><xref rid="R43" ref-type="bibr">43</xref></p><p>Currently commonly used H<sub>2</sub>S donors are aqueous solutions of sodium sulfide (Na<sub>2</sub>S) and NaHS. However, the release H<sub>2</sub>S from these sulfide salts is spontaneous and rapid, making the delivered concentration of H<sub>2</sub>S difficult to control. Several synthetic donors capable of releasing H<sub>2</sub>S under physiological conditions have been reported to be developed but have not yet been used in PD-related studies.<xref rid="R20" ref-type="bibr">20</xref></p><p><bold>Conclusion:</bold> Increasing evidence has shown that H<sub>2</sub>S has a neuroprotective effect on many degenerative diseases of the central nervous system, such as PD. PD is the second most common neurodegenerative disease in the world. Currently, drug treatment focuses mainly on symptom control and cannot effectively reverse the disease process. Therefore, it is very important to develop new treatment options. This article reviews the basic research on H<sub>2</sub>S in PD in recent years. H<sub>2</sub>S reduces or even reverses the apoptosis of dopaminergic neurons in animal models through anti-inflammatory, anti-apoptotic, and anti-oxidative stress, and improves behavioral function, indicating the therapeutic potential of H<sub>2</sub>S. However, current technology cannot detect the concentration of H<sub>2</sub>S in the substantia nigra and striatum in real time, nor can it allow the stable release of H<sub>2</sub>S in the brain. There are still many difficulties to overcome before H<sub>2</sub>S can be used in clinical practice.</p><p><italic toggle="yes">Gang Chen is an Editorial Board member of Medical Gas Research. He is blinded from reviewing or making decisions on the manuscript. The article was subject to the journal &#x02019;s standard procedures, with peer review handled independently of this Editorial Board member and his research group</italic>.</p></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagpure</surname><given-names>BV</given-names></name>
<name><surname>Bian</surname><given-names>JS</given-names></name></person-group><article-title>Brain, learning, and memory: role of H2S in neurodegenerative diseases</article-title><source>Handb Exp Pharmacol</source><year>2015</year><volume>230</volume><fpage>193</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">26162836</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>B</given-names></name>
<name><surname>Bhattacharya</surname><given-names>R</given-names></name>
<name><surname>Mukherjee</surname><given-names>P</given-names></name></person-group><article-title>Hydrogen sulfide signaling in mitochondria and disease</article-title><source>FASEB J</source><year>2019</year><volume>33</volume><fpage>13098</fpage><lpage>13125</lpage><pub-id pub-id-type="pmid">31648556</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dilek</surname><given-names>N</given-names></name>
<name><surname>Papapetropoulos</surname><given-names>A</given-names></name>
<name><surname>Toliver-Kinsky</surname><given-names>T</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide: an endogenous regulator of the immune system</article-title><source>Pharmacol Res</source><year>2020</year><volume>161</volume><fpage>105119</fpage><pub-id pub-id-type="pmid">32781284</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>LF</given-names></name>
<name><surname>Lu</surname><given-names>M</given-names></name>
<name><surname>Hon</surname><given-names>Wong PT</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide: neurophysiology and neuropathology</article-title><source>Antioxid Redox Signal</source><year>2011</year><volume>15</volume><fpage>405</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">20812864</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>X</given-names></name>
<name><surname>Cao</surname><given-names>L</given-names></name>
<name><surname>Ding</surname><given-names>L</given-names></name>
<etal/></person-group><article-title>A new hope for a devastating disease: hydrogen sulfide in Parkinson&#x02019;s disease</article-title><source>Mol Neurobiol</source><year>2018</year><volume>55</volume><fpage>3789</fpage><lpage>3799</lpage><pub-id pub-id-type="pmid">28536975</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Bian</surname><given-names>JS</given-names></name></person-group><article-title>Hydrogen sulfide: a neuromodulator and neuroprotectant in the central nervous system</article-title><source>ACS Chem Neurosci</source><year>2014</year><volume>5</volume><fpage>876</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">25230373</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>H</given-names></name>
<name><surname>Nagai</surname><given-names>Y</given-names></name>
<name><surname>Umemura</surname><given-names>K</given-names></name>
<etal/></person-group><article-title>Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation</article-title><source>Antioxid Redox Signal</source><year>2005</year><volume>7</volume><fpage>795</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">15890027</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Zhang</surname><given-names>S</given-names></name>
<name><surname>Shan</surname><given-names>H</given-names></name>
<etal/></person-group><article-title>Biologic effect of hydrogen sulfide and its role in traumatic brain injury</article-title><source>Oxid Med Cell Longev</source><year>2020</year><volume>2020</volume><fpage>7301615</fpage><pub-id pub-id-type="pmid">33425216</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>H</given-names></name>
<name><surname>Pan</surname><given-names>P</given-names></name>
<name><surname>Yang</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral haemorrhage in rats</article-title><source>J Neuroinflammation</source><year>2017</year><volume>14</volume><fpage>163</fpage><pub-id pub-id-type="pmid">28821266</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shan</surname><given-names>H</given-names></name>
<name><surname>Qiu</surname><given-names>J</given-names></name>
<name><surname>Chang</surname><given-names>P</given-names></name>
<etal/></person-group><article-title>Exogenous hydrogen sulfide offers neuroprotection on intracerebral hemorrhage injury through modulating endogenous H(2)S metabolism in mice</article-title><source>Front Cell Neurosci</source><year>2019</year><volume>13</volume><fpage>349</fpage><pub-id pub-id-type="pmid">31440142</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide alleviates oxidative stress injury and reduces apoptosis induced by MPP(+) in Parkinson&#x02019;s disease cell model</article-title><source>Mol CellBiochem</source><year>2020</year><volume>472</volume><fpage>231</fpage><lpage>240</lpage></element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raza</surname><given-names>C</given-names></name>
<name><surname>Anjum</surname><given-names>R</given-names></name>
<name><surname>Shakeel</surname><given-names>NUA</given-names></name></person-group><article-title>Parkinson&#x02019;s disease: mechanisms, translational models and management strategies</article-title><source>Life Sci</source><year>2019</year><volume>226</volume><fpage>77</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">30980848</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ascherio</surname><given-names>A</given-names></name>
<name><surname>Schwarzschild</surname><given-names>MA</given-names></name></person-group><article-title>The epidemiology of Parkinson&#x02019;s disease: risk factors and prevention</article-title><source>Lancet Neurol</source><year>2016</year><volume>15</volume><fpage>1257</fpage><lpage>1272</lpage><pub-id pub-id-type="pmid">27751556</pub-id>
</element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Minaei</surname><given-names>A</given-names></name>
<name><surname>Sarookhani</surname><given-names>MR</given-names></name>
<name><surname>Haghdoost-Yazdi</surname><given-names>H</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopa-mine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress</article-title><source>Toxicol Appl Pharmacol</source><year>2021</year><volume>423</volume><fpage>115558</fpage><pub-id pub-id-type="pmid">33961902</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balestrino</surname><given-names>R</given-names></name>
<name><surname>Schapira</surname><given-names>AHV</given-names></name></person-group><article-title>Parkinson disease</article-title><source>Eur J Neurol</source><year>2020</year><volume>27</volume><fpage>27</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">31631455</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>M</given-names></name>
<name><surname>Tazzari</surname><given-names>V</given-names></name>
<name><surname>Giustarini</surname><given-names>D</given-names></name>
<etal/></person-group><article-title>Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>17318</fpage><lpage>17328</lpage><pub-id pub-id-type="pmid">20368333</pub-id>
</element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Armstrong</surname><given-names>MJ</given-names></name>
<name><surname>Okun</surname><given-names>MS</given-names></name></person-group><article-title>Diagnosis and treatment of Parkinson disease: a review</article-title><source>JAMA</source><year>2020</year><volume>323</volume><fpage>548</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">32044947</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>M</given-names></name>
<name><surname>Zhao</surname><given-names>FF</given-names></name>
<name><surname>Tang</surname><given-names>JJ</given-names></name>
<etal/></person-group><article-title>The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels</article-title><source>Antioxid Redox Signal</source><year>2012</year><volume>17</volume><fpage>849</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">22360462</pub-id>
</element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>R</given-names></name></person-group><article-title>Physiological implications of hydrogen sulfide: a whiff exploration that blossomed</article-title><source>Physiol Rev</source><year>2012</year><volume>92</volume><fpage>791</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">22535897</pub-id>
</element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali</surname><given-names>R</given-names></name>
<name><surname>Pal</surname><given-names>HA</given-names></name>
<name><surname>Hameed</surname><given-names>R</given-names></name>
<etal/></person-group><article-title>Controlled release of hydrogen sulfide significantly reduces ROS stress and increases dopamine levels in transgenic C. elegans</article-title><source>Chem Commun (Camb)</source><year>2019</year><volume>55</volume><fpage>10142</fpage><lpage>10145</lpage><pub-id pub-id-type="pmid">31389424</pub-id>
</element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olson</surname><given-names>KR</given-names></name></person-group><article-title>H(2)S and polysulfide metabolism: conventional and unconventional pathways</article-title><source>Biochem Pharmacol</source><year>2018</year><volume>149</volume><fpage>77</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">29248597</pub-id>
</element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paul</surname><given-names>BD</given-names></name>
<name><surname>Snyder</surname><given-names>SH</given-names></name>
<name><surname>Kashfi</surname><given-names>K</given-names></name></person-group><article-title>Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics</article-title><source>Redox Biol</source><year>2021</year><volume>38</volume><fpage>101772</fpage><pub-id pub-id-type="pmid">33137711</pub-id>
</element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide: its production, release and functions</article-title><source>Amino Acids</source><year>2011</year><volume>41</volume><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">20191298</pub-id>
</element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>M</given-names></name>
<name><surname>Schwab</surname><given-names>C</given-names></name>
<name><surname>Yu</surname><given-names>S</given-names></name>
<etal/></person-group><article-title>Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide</article-title><source>Neurobiol Aging</source><year>2009</year><volume>30</volume><fpage>1523</fpage><lpage>1534</lpage><pub-id pub-id-type="pmid">19631409</pub-id>
</element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Wang</surname><given-names>C</given-names></name>
<etal/></person-group><article-title>NaSH increases SIRT1 activity and autoph-agy flux through sulfhydration to protect SH-SY5Y cells induced by MPP~</article-title><source>Cell Cycle</source><year>2020</year><volume>19</volume><fpage>2216</fpage><lpage>2225</lpage><pub-id pub-id-type="pmid">32787548</pub-id>
</element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide as a neuromodulator</article-title><source>Mol Neurobiol</source><year>2002</year><volume>26</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">12392053</pub-id>
</element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>267</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">10623586</pub-id>
</element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>LF</given-names></name>
<name><surname>Lu</surname><given-names>M</given-names></name>
<name><surname>Wu</surname><given-names>ZY</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function</article-title><source>Mol Pharmacol</source><year>2009</year><volume>75</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18832435</pub-id>
</element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Georgieva</surname><given-names>E</given-names></name>
<name><surname>Ivanova</surname><given-names>D</given-names></name>
<name><surname>Zhelev</surname><given-names>Z</given-names></name>
<etal/></person-group><article-title>Mitochondrial dysfunction and redox imbalance as a diagnostic marker of &#x0201c;free radical diseases&#x0201d;</article-title><source>Anticancer Res</source><year>2017</year><volume>37</volume><fpage>5373</fpage><lpage>5381</lpage><pub-id pub-id-type="pmid">28982845</pub-id>
</element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tabassum</surname><given-names>R</given-names></name>
<name><surname>Jeong</surname><given-names>NY</given-names></name></person-group><article-title>Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases</article-title><source>Int J Med Sci</source><year>2019</year><volume>16</volume><fpage>1386</fpage><lpage>1396</lpage><pub-id pub-id-type="pmid">31692944</pub-id>
</element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Physiological role of hydrogen sulfide and polysulfide in the central nervous system</article-title><source>Neurochem Int</source><year>2013</year><volume>63</volume><fpage>492</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">24036365</pub-id>
</element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>Y</given-names></name>
<name><surname>Goto</surname><given-names>Y</given-names></name>
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria</article-title><source>Antioxid Redox Signal</source><year>2010</year><volume>12</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">19852698</pub-id>
</element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>XQ</given-names></name>
<name><surname>Fan</surname><given-names>LL</given-names></name>
<name><surname>Li</surname><given-names>YJ</given-names></name>
<etal/></person-group><article-title>Inhibition of hydrogen sulfide generation contributes to 1-methy-4-phenylpyridinium ion-induced neurotoxicity</article-title><source>Neurotox Res</source><year>2011</year><volume>19</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">20361290</pub-id>
</element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>LF</given-names></name>
<name><surname>Lu</surname><given-names>M</given-names></name>
<name><surname>Tiong</surname><given-names>CX</given-names></name>
<etal/></person-group><article-title>Neuroprotective effects of hydrogen sulfide on Parkinson&#x02019;s disease rat models</article-title><source>Aging Cell</source><year>2010</year><volume>9</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">20041858</pub-id>
</element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiao</surname><given-names>M</given-names></name>
<name><surname>Wang</surname><given-names>W</given-names></name>
<name><surname>Gao</surname><given-names>Z</given-names></name></person-group><article-title>Protective effect of hydrogen sulfide against neuronal apoptosis via inhibiting neuroinflammation in Parkinson rats</article-title><source>Int J Clin Exp Med</source><year>2019</year><volume>12</volume><fpage>4935</fpage><lpage>4941</lpage></element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Q</given-names></name>
<name><surname>Li</surname><given-names>F</given-names></name>
<name><surname>Liu</surname><given-names>X</given-names></name>
<etal/></person-group><article-title>Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy</article-title><source>Nat Med</source><year>2011</year><volume>17</volume><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">21725296</pub-id>
</element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marogianni</surname><given-names>C</given-names></name>
<name><surname>Sokratous</surname><given-names>M</given-names></name>
<name><surname>Dardiotis</surname><given-names>E</given-names></name>
<etal/></person-group><article-title>Neurodegeneration and inflammation-an interesting interplay in Parkinson&#x02019;s disease</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><fpage>8421</fpage><pub-id pub-id-type="pmid">33182554</pub-id>
</element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belarbi</surname><given-names>K</given-names></name>
<name><surname>Cuvelier</surname><given-names>E</given-names></name>
<name><surname>Bonte</surname><given-names>MA</given-names></name>
<etal/></person-group><article-title>Glycosphingolipids and neuroinflammation in Parkinson&#x02019;s disease</article-title><source>Mol Neurodegener</source><year>2020</year><volume>15</volume><fpage>59</fpage><pub-id pub-id-type="pmid">33069254</pub-id>
</element-citation></ref><ref id="R39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kida</surname><given-names>K</given-names></name>
<name><surname>Yamada</surname><given-names>M</given-names></name>
<name><surname>Tokuda</surname><given-names>K</given-names></name>
<etal/></person-group><article-title>Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson&#x02019;s disease</article-title><source>Antioxid Redox Signal</source><year>2011</year><volume>15</volume><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">21050138</pub-id>
</element-citation></ref><ref id="R40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>M</given-names></name>
<name><surname>Zhu</surname><given-names>J</given-names></name>
<name><surname>Pan</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson&#x02019;s disease</article-title><source>J Neurosci Res</source><year>2015</year><volume>93</volume><fpage>487</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">25388401</pub-id>
</element-citation></ref><ref id="R41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>L</given-names></name>
<name><surname>Tiong</surname><given-names>CX</given-names></name>
<name><surname>Bian</surname><given-names>JS</given-names></name></person-group><article-title>Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress</article-title><source>Am J Physiol Cell Physiol</source><year>2012</year><volume>303</volume><fpage>C81</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">22555844</pub-id>
</element-citation></ref><ref id="R42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>H</given-names></name>
<name><surname>Shibuya</surname><given-names>N</given-names></name>
<name><surname>Kimura</surname><given-names>Y</given-names></name></person-group><article-title>Hydrogen sulfide is a signaling molecule and a cytoprotectant</article-title><source>Antioxid Redox Signal</source><year>2012</year><volume>17</volume><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">22229673</pub-id>
</element-citation></ref><ref id="R43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>H</given-names></name>
<name><surname>Yu</surname><given-names>H</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide and endoplasmic reticulum stress: a potential therapeutic target for central nervous system degeneration diseases</article-title><source>Front Pharmacol</source><year>2020</year><volume>11</volume><fpage>702</fpage><pub-id pub-id-type="pmid">32477150</pub-id>
</element-citation></ref></ref-list></back></article>